Home – Healthcarewriter

Post Menopausal Vaginal Atrophy Market

(Albany, US) DelveInsight’s “Post Menopausal Vaginal Atrophy Market Insights, Epidemiology, and Market Forecast-2032” report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Post menopausal vaginal atrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key facts of the Post Menopausal Vaginal Atrophy Market

According to the American Association of Family Physicians, up to 40 percent of postmenopausal women have symptoms of atrophic vaginitis. While 15% of the female population experiences symptoms of vaginal atrophy before menopause.
While vaginal atrophy is common, only 20 to 25 percent of symptomatic women seek medical attention from their doctor.
European Vulvovaginal Epidemiological Survey examined >2,000 postmenopausal women. Symptoms of Vaginal Atrophy were detected in 90% of women. According to the results of the survey, the quality of life in this group of women was significantly lower in comparison to that of women of postmenopausal age without symptoms of Vaginal Atrophy.

Request for Sample Report:

https://www.delveinsight.com/sample-request/postmenopausal-vaginal-atrophy-market

View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market

Key benefits of the Post Menopausal Vaginal AtrophyMarket report:

The study provides a detailed review of Post Menopausal Vaginal Atrophy, including its causes, signs and symptoms, pathophysiology, diagnosis, and current treatments.
Study of the 7MM has offered comprehensive insight into the epidemiology and management of Post Menopausal Vaginal Atrophy.
Furthermore, an all-inclusive description of both present and emergingPost Menopausal Vaginal Atrophy treatments is offered, as well as an analysis of future therapies that will have an influence on the current treatment landscape.
The research includes a full evaluation of the Post Menopausal Vaginal Atrophy market, both historical and anticipated, as well as drug outreach in the 7MM population.
By understanding the trends defining and driving the worldwide Post Menopausal Vaginal Atrophy market, the study gives you an advantage when formulating business plans.

Post Menopausal Vaginal Atrophy Overview

Postmenopausal atrophic vaginitis, or vaginal atrophy, is the thinning of the walls of the vagina caused by decreased estrogen levels. Without estrogen, vaginal tissue thins and dries out. It becomes less elastic, more fragile, and more easily injured. This most commonly occurs after menopause. Women with vaginal atrophy have a greater chance of chronic vaginal infections and urinary function problems. It can also make sexual intercourse painful. Symptoms can include: thinning of the vaginal walls, shortening and tightening of the vaginal canal, lack of vaginal moisture, vaginal burning, spotting after intercourse, discomfort or pain during intercourse, pain or burning with urination, more frequent urinary tract infections, and/or urinary incontinence.

Atrophic vaginitis increases a woman’s risk of contracting vaginal infections. Atrophy causes changes in the acidic environment of the vagina, making it easier for bacteria, yeast, and other organisms to thrive. It also increases the risk of urinary system atrophy (genitourinary atrophy). Symptoms associated with atrophy-related urinary tract problems include more frequent or more urgent urination or a burning sensation during urination.

Postmenopausal atrophic vaginitis is often diagnosed through a physical examination, pelvic examination, vaginal smear test, vaginal acidity test, blood test and urine test. With treatment, it’s possible to improve your vaginal health and your quality of life. Estrogen replacement therapy and Over-the-counter moisturizers or water-based lubricants can help treat dryness.

View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market

Post Menopausal Vaginal Atrophy Market

The report’s Post Menopausal Vaginal Atrophy market outlook assists in developing a detailed understanding of historic, current, and forecasted Post Menopausal Vaginal Atrophy market trends by analyzing the impact of current Post Menopausal Vaginal Atrophy therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This section examines the Post Menopausal Vaginal Atrophy market trend of each marketed drug and late stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing market need, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, market impact, and key opinion leaders’ perspectives. Post Menopausal Vaginal Atrophy market statistics are supplied with pertinent tables and graphs to provide a comprehensive picture of the market at a glance. According to DelveInsight, the Post Menopausal Vaginal Atrophy market in 7MM is expected to undergo significant change between 2019 and 2032.

Learn more by requesting for sample @ Post Menopausal Vaginal Atrophy Market Landscape

Post Menopausal Vaginal Atrophy Companies

Novo Nordisk A/S
PepTonic Medical AB
Pharma Consulting Group AB
Italfarmaco S.A
And Many More

View Report: https://www.delveinsight.com/report-store/postmenopausal-vaginal-atrophy-market

Post Menopausal Vaginal Atrophy Pipeline

Estradiol
Estriol
Oxytocin
And Many More

Know more about the pipeline therapies and recent developments @ Post Menopausal Vaginal Atrophy Pipeline Report

Table of Contents

Key Insights
Executive Summary of Postmenopausal Vaginal Atrophy
Competitive Intelligence Analysis for Postmenopausal Vaginal Atrophy
Postmenopausal Vaginal Atrophy: Market Overview at a Glance
Postmenopausal Vaginal Atrophy: Disease Background and Overview
Patient Journey
Postmenopausal Vaginal Atrophy Epidemiology and Patient Population
Treatment Algorithm, Current Treatment, and Medical Practices
Postmenopausal Vaginal Atrophy Unmet Needs
Key Endpoints of Postmenopausal Vaginal Atrophy Treatment
Postmenopausal Vaginal Atrophy Marketed Products
Postmenopausal Vaginal Atrophy Emerging Therapies
Postmenopausal Vaginal Atrophy: Seven Major Market Analysis
Attribute analysis
7MM: Market Outlook
Access and Reimbursement Overview of Postmenopausal Vaginal Atrophy
KOL Views
Market Drivers
Market Barriers
Appendix
DelveInsight Capabilities
Disclaimer
About DelveInsight

Click here to read more about Post Menopausal Vaginal Atrophy Market Outlook 2032

Related Reports by DelveInsight:

Other Reports:

Related Blogs:

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Shambhavi Verma

Email: info@delveinsight.com

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

March 22, 2022

Market Research Report, Pharmaceutical, Uncategorized

Vernal Keratoconjunctivitis Market

(Albany, US) DelveInsight’s “Vernal Keratoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2030” report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Vernal Keratoconjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key facts of the Vernal Keratoconjunctivitis Market

The increasing population and rising prevalence of Vernal Keratoconjunctivitis generates a large patient population in the global market. In 2017, a total of 4,752,356 patients were affected by Vernal Keratoconjunctivitis in the global market.
China contributes the largest share among EU-5, and Japan, with 2,248,706 cases in 2017.
The total diagnosed prevalent population of Vernal Keratoconjunctivitis was 2,943,057 in the global market.

Request for Sample Report: https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market

Key benefits of the Vernal Keratoconjunctivitis Market report

The study provides a detailed review of Vernal Keratoconjunctivitis, including its causes, signs and symptoms, pathophysiology, diagnosis, and current treatments.
Study of the 7MM has offered comprehensive insight into the epidemiology and management of Vernal Keratoconjunctivitis.
Furthermore, an all-inclusive description of both present and emerging Vernal Keratoconjunctivitis treatments is offered, as well as an analysis of future therapies that will have an influence on the current treatment landscape.
The research includes a full evaluation of the Vernal Keratoconjunctivitis market, both historical and anticipated, as well as drug outreach in the 7MM population.
By understanding the trends defining and driving the worldwide Vernal Keratoconjunctivitis market, the study gives you an advantage when formulating business plans.

Vernal Keratoconjunctivitis Overview

Vernal Keratoconjunctivitis (VKC) is a relatively rare, chronic form of ocular allergy that can potentially cause severe visual complications. Affecting mainly children and young adults, it is an IgE- and T cell-mediated disease, leading to a chronic inflammation in which eosinophil, lymphocyte and structural cell activation are involved. Treatment of Vernal Keratoconjunctivitis requires a multiple approach that includes conservative measures and pharmacologic treatment. Signs and symptoms usually begin before 10 years of age and may include hard, cobblestone-like bumps (papillae) on the upper eyelid; sensitivity to light; redness; sticky mucus discharge; and involuntary blinking or spasms of the eyelid. Management focuses on preventing “”flare ups”” and relieving the symptoms of the condition. It is often recommended that affected individuals try to avoid the agent that causes the allergy (if possible); wear dark sunglasses in the daytime; avoid dust; and stay inside on hot afternoons. Topical eye drops are generally preferred as the first source of treatment. Cold compresses, artificial tears, ointments and/or topical antihistamines may help. Non-steroid anti-inflammatory drugs (NSAIDS) may relieve symptoms in moderate cases; topical steroids are typically only used for more severe cases because long-term use can cause glaucoma.

Request for Sample Report: https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market

Vernal Keratoconjunctivitis Market

The report’s Vernal Keratoconjunctivitis market outlook assists in developing a detailed understanding of historic, current, and forecasted Vernal Keratoconjunctivitis market trends by analyzing the impact of current Vernal Keratoconjunctivitis therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This section examines the Vernal Keratoconjunctivitis market trend of each marketed drug and late stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing market need, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, market impact, and key opinion leaders’ perspectives. Vernal Keratoconjunctivitis market statistics are supplied with pertinent tables and graphs to provide a comprehensive picture of the market at a glance. According to DelveInsight, the Vernal Keratoconjunctivitis market in 7MM is expected to undergo significant change between 2019 and 2032.

Request for Sample Report: https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market

Vernal Keratoconjunctivitis Companies

Santen SAS

Allakos, Inc.
Novartis
Astellas Pharma Inc
Laboratoires Thea
And Many More

Vernal Keratoconjunctivitis Pipeline

NOVA22007 ‘’Ciclosporin”
AK002
Cyclosporine A
Dexamethasone
FK506
NAAXIA Sine
And Many More

Request for Sample Report: https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market

Table of Contents

Key Insights
Executive Summary of Vernal keratoconjunctivitis (VKC)
Vernal keratoconjunctivitis (VKC): Market Overview at a Glance
Disease Background and Overview: Vernal keratoconjunctivitis (VKC)
Case Reports
Epidemiology and Patient Population
United States Epidemiology
EU5 Epidemiology
Japan Epidemiology
MEA Region Epidemiology
China Epidemiology
Russia Epidemiology
Current Treatment and Medical Practices
Unmet Needs
Marketed Drugs
Emerging Drugs
Vernal Keratoconjunctivitis (VKC): 7MM Market Analysis
United States
EU-5 countries
Japan
MEA countries Market Outlook
China: Market Outlook
Russia Market Outlook
Market Drivers
Market Barriers
Reimbursement and Market Access
SWOT Analysis
KOL Views
Appendix
DelveInsight Capabilities
Disclaimer
About DelveInsight

Related Reports by DelveInsight:

Other Reports:

Related Blogs:

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Shambhavi Verma

Email: info@delveinsight.com

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

March 22, 2022

Market Research Report, Pharmaceutical, Uncategorized

Vernal Keratoconjunctivitis, Vernal Keratoconjunctivitis Market

Image Guided Surgery Device Market

DelveInsight’s “Image Guided Surgery Devices Market Insights, Competitive Landscape and Market Forecast-2026” report delivers an in-depth understanding of the Image Guided Surgery Devices, historical and forecasted epidemiology as well as the Image Guided Surgery Devices market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Recent developmental activities in Image Guided Surgery Devices market

According to DelveInsight, the global Image Guided Surgery Devices market will increase at a CAGR of 7.27 percent during the forecasted period from 2021 to 2026, to reach USD 4.79 billion by 2026.
In August 2021, Lightpoint Medical and Telix Pharmaceuticals entered into a strategic partnership agreement to explore the potential of integrating their technologies for radio-guided surgery (RGS) to spot cancer in real-time.
In December 2020, Philips collaborated with InSightec to expand access to MR-guided focused ultrasound for incision-less neurosurgery. Under this collaboration partnership, the companies are focused to develop compatibility between Philips’ advanced MR systems and the Exablate Neuro platform.
In October 2020, Brainlab AG received FDA clearance for its Cranial Image-guided Surgery System.
In December 2020, medPhoton GmbH received FDA approval for its Mobile ImagingRing System which is a robotic digital X-ray system enabling image-guided operations in medical fields such as general surgery, traumatology, orthopedics, neurology, or radiotherapy.
On March 10, 2020, Interventional Systems released its new robotic platform, Micromate™ for use in Europe. The system is indicated for any image-guided procedure that involves placing or manipulating instruments based on acquired radiology or real-time images with, or without, optical navigation.
In May 2020, Jiangsu Rayer Medical Technology Co., Ltd. received FDA clearance for its image guidance system for radiotherapy intended to be used in combination with the radiotherapy device, for real-time tracking of target motion for patient radiation therapy.

For more insights intoImage Guided Surgery Devices, get the snapshot of the key highlights entailed in the Image Guided Surgery Devices Report

Image Guided Surgery Devices Overview

The utilization of a real-time correlation of the operational field to a preoperative imaging data collection that reflects the precise placement of a selected surgical tool to the surrounding anatomic structures is known as image-guided surgery (IGS). Although endoscopic sinus surgery (ESS) was first designed for neurosurgery, it quickly became one of the main indications for this technology. Most CT scanners now produce data sets that are compatible with frequently used guiding systems. Radiography can alternatively deliver the necessary data on a CD-ROM or send images directly from the radiology station to the image guided surgical system through a secure internet network. These advances, as well as the decreasing cost of the technology, have allowed Image guided surgery to be available to a sizable number of otolaryngologists. Image-guided endoscopic sinus surgery is also reaching increasing acceptance in pediatric otolaryngology, although fewer reports have been published compared with the adult literature.

Interested in knowing how the Image Guided Surgery Devices Market will be growing by 2026? Click to get a snapshot of Image Guided Surgery Devices Market Analysis

Geography Wise- Image Guided Surgery Devices Market Analysis

The Image Guided Surgery Devices market is analyzed geographically for North America, Europe, Asia-Pacific, and the Rest of the World. Among all the regions, North America is expected to hold a major share in the overall image-guided surgery devices market during the forecasted period. This domination is due to the rising burden of the population in the region suffering from chronic disorders. Moreover, the rapidly growing old age population in the country in comparison to previous years and the growing prevalence of cardiology and cardiovascular disorders such as coronary artery disease, heart blockage, heart attack, among others are also factors contributing to the rising market for image-guided surgery devices. In addition, the presence of a proper reimbursement policy for image-guided surgeries along with advanced and well-established healthcare infrastructure, among others will spur the market for image-guided surgery devices. Furthermore, the presence of key manufacturers such as Varian Medical Systems, Inc., Medtronic, GE Healthcare, among others active in the production of image-guided surgery systems is anticipated to fuel the market for the image-guided surgery systems in the region.

Moreover, the occurrence of various strategic business activities in the region such as company collaborations, acquisitions, product launch, and approval, among others are also expected to propel the market for image-guided surgery systems in the region.

Segmentation

By Product Type

Ultrasound Systems, Endoscopes
Magnetic Resonance Imaging [MRI] Systems
Computed Tomography [CT] Systems
X-Ray Fluoroscopy Systems
Others

By Application

Neurology
Oncology Surgery
ENT Surgery
Orthopedic Surgery
Others

By End-User

Hospitals
Specialty Clinics
And Others

By Geography

North America
Europe
Asia-Pacific
Rest of the World

Get a sneak peek at the Image Guided Surgery Devices market dynamics @ Image Guided Surgery Devices Market Drivers Analysis

Image Guided Surgery Devices Market Segment Analysis

The market for image-guided surgery devices is gaining momentum at present owing to the increasing prevalence and incidence of chronic disorders such as neurological disorders, cardiovascular disorders, cancers, among others worldwide. The rising prevalence and incidence of cancer will contribute to the market for image-guided surgery devices as it improves the surgical outcome for cancer surgeries. Moreover, shifting patient preferences towards minimally invasive surgeries could also boosts the demand for image-guided surgery devices.

Furthermore, technological advances such as higher resolution imaging, 3D imaging, and robotics that have allowed practitioners for carrying out more effective and accurate surgeries which reduces the length of hospitalization and lower the risk of revision surgeries will contribute to the increasing demand for image-guided surgery systems. In addition, the rise in product approvals of advanced image-guided surgery devices is also a potential factor leading to the market growth during the forecasted period. Thus, all the aforementioned factors are expected to augment the global market for image-guided surgery devices. The high cost of the surgery machine and stringent regulatory approval process for these systems are likely to impede the market for image-guided surgery devices.

Impact of Covid-19 on Image Guided Surgery Devices Market

The unprecedented COVID-19 pandemic has had a significant impact on the market for image-guided surgery devices. This is due to the fact that surgery increases the chance of infection transmission since surgery requires cutting, abrading, and suturing, which cannot be conducted without coming into contact. As a result, patients avoided attending hospitals in order to avoid infection transmission. Stringent standards set by various governments throughout the world, as well as delays in many elective procedures and a halt in production facilities, have all hampered the market for image-guided surgery devices. However, the global launch of several vaccines and the deployment of a mass vaccination effort are projected to normalize post-pandemic market growth.

Image Guided Surgery Devices Market Scope

Study Period: 2018-2026

Key Companies: Koninklijke Philips N.V., Medtronic, Siemens Healthineers, General Electric Company, Varian Medical Systems, Inc., Brainlab AG, Quest Photonic Devices (Olympus), Stryker, Abbott, inomed Medizintechnik GmbH, Accuray Incorporated, medPhoton GmbH, 7D Surgical, OnLume Inc., IMRIS, Shimadzu Corporation, FUJIFILM Holdings, Nanjing Perlove Medical Equipment Co., Ltd., Allengers, Elekta AB, and others.

Segmentation: By Product Type, By Application, By End-User, By geography

Geography Covered: North America, Europe, Asia- Pacific, Rest of the World (Middle East, Africa, and South America)

Know more about which MedTech player is set to emerge as the trendsetter @ Key Image Guided Surgery Devices Companies

Table of Contents

Image-guided Surgery Devices Market Report Introduction
Image-guided Surgery Devices Market Executive summary
Regulatory and Patent Analysis
Image-guided Surgery Devices Market Key factors analysis
Image-guided Surgery Devices Porter’s Five Forces Analysis
COVID-19 Impact Analysis on Image-guided Surgery Devices Market
Image-guided Surgery Devices Market layout
Image-guided Surgery Devices Global Company Share Analysis – Key 3-5 Companies
Image-guided Surgery Devices Company and Product Profiles
KOL Views
Project Approach
About DelveInsight
Disclaimer & Contact Us

Learn more about the Image Guided Surgery Devices @ Image Guided Surgery Devices Regulatory And Patent Analysis

Other Reports:

Related Blogs:

About Delveinsight:

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Ankit Nigam

Email: info@delveinsight.com

Phone: +19193216187

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com/

Connect With Us at:

LinkedIn | Facebook | Twitter

March 19, 2022

Market Research Report, Medical Device

Image Guided Surgery Device, Image Guided Surgery Device Market

Ophthalmic Imaging Equipment Market

DelveInsight’s “Ophthalmic Imaging Equipment Market Insights, Competitive Landscape and Market Forecast-2026” report delivers an in-depth understanding of the Ophthalmic Imaging Equipment, historical and forecasted epidemiology as well as the Ophthalmic Imaging Equipment market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Recent developmental activities in Ophthalmic Imaging Equipment market

According to DelveInsight, the Ophthalmic Imaging Equipment market will increase at a CAGR of 5.96 percent during the forecasted period from 2021 to 2026, to reach USD 3.11 billion by 2026.
In October 2021, NIDEK CO LTD. launched the Retina Scan Duo 2, a combined OCT and fundus camera system. The system comes equipped with new features designed to enhance screening and clinical efficiency, in addition to user-friendly features that were incorporated from the previous model.
In October 2021, iCare USA received the 510k approval from the US Food and Drug Administration for their EIDON Ultra-Widefield Lens module which is capable of capturing 120 degrees images of the retina in a single shot or in mosaic function mode, images up to 200 degrees.
In June 2021, Konan Medical Inc. received the 510k approval from the US FDA for their CellCheck 20 rc software program which is intended to be used with the specular microscope XVII.

For more insights into Ophthalmic Imaging Equipment Market, get the snapshot of the key highlights entailed in the Ophthalmic Imaging Equipment Report

Ophthalmic Imaging Equipment Overview

Ophthalmic Imaging is the use of specialist equipment to create detailed images to support the diagnosis and treatment of a range of eye conditions. Various common procedures carried out include;

Optical Coherence Tomography- A non-invasive diagnostic test which uses a low powered laser to scan and image the inner layers of the retina. OCT can help diagnose various eye diseases such as age related macular degeneration, macular oedema and glaucoma.
Fundus Fluorescein Angiography (FFA) and Indocyanine Green Angiography (ICG)- A process used to detect abnormalities in the retinal and choroidal layers of the inner eye.
Fundus Photography- Using special cameras, ophthalmic imaging technicians are able to produce detailed photographs of the inside of the eye.
Anterior Segment Photography- The outer areas of the eye may require photography to document changes and/or treatment to the eyelid, cornea, iris, lens and sclera.
Corneal Topography and OCT- The imaging and mapping of the cornea. This can aid the clinician when diagnosing, planning, and recording conditions related to the cornea.

The demand for ophthalmic imaging equipment is primarily being boosted by the rising prevalence of diabetes and growing geriatric population base which has resulted in the increased prevalence of ocular diseases of different etiologies, increasing number of image-guided surgeries, and technical innovation in product development which are expected to increase in the product demand thereby contributing in the growth of the ophthalmic imaging equipment market during the forecast period from 2021-2026.

Interested in knowing how the Ophthalmic Imaging Equipment Market will be growing by 2026? Click to get a snapshot of Ophthalmic Imaging Equipment Analysis

Geography Wise- Ophthalmic Imaging Equipment s Market Analysis

The Ophthalmic Imaging Equipment market is analyzed geographically for North America, Europe, Asia-Pacific, and the Rest of the World. Among all the regions, Asia-Pacific is expected to account for the significant market share in the ophthalmic imaging equipment market. Because of the high prevalence of diabetes, the presence of a large patient population suffering from ocular diseases, and the increasing focus on the improvement of healthcare infrastructure in various countries throughout the region, APAC is expected to have the fastest growth in the ophthalmic imaging equipment market.

According to World Health Organization estimates, a projected 596 million individuals globally have distant visual impairment in 2020, with 43 million being blind. Furthermore, according to World Economic Forum estimations, the APAC region’s GDP has climbed from USD 15,133.08 billion to a predicted GDP of 30,280.20 billion by 2024. The growth in GDP reflects the region’s increased disposable income, which will improve the spending power of customers, including healthcare services. In China, for example, in addition to the three-tier eye care network of the provincial municipality, the county-township-village three-tier eye care network is also being established to ensure access to eye care at the basic level.

Segmentation

By Product Type

Optical Coherence Tomography Systems
Ophthalmic Ultrasound Systems
Fundus Cameras, Slit Lamps
Corneal Topography Systems
Specular Microscopes
and Others

By Application

Glaucoma
Cataract
Retinopathies
Age-Related Macular Degeneration
and Others

By End User

Hospitals
Specialty Clinics
and Others

By Geography

North America
Europe
Asia-Pacific
Rest of the World

Get a sneak peek at the Ophthalmic Imaging Equipment market dynamics @ Ophthalmic Imaging Equipment Market Drivers Analysis

Ophthalmic Imaging Equipment Market Segment Analysis

In the product segment of the Ophthalmic Imaging Equipment Market, the Ophthalmic Coherence Tomography-based imaging equipment is expected to hold a significant share in the ophthalmic imaging equipment market in the forecast period. This can be attributed to the advantages of OCT over older methods namely scan speed, non-invasive nature, and the generation of the three-dimensional data. Unlike conventional angiography methods based on fundus photography or scanning laser ophthalmoscopy (SLO), OCT-Angiography techniques provide depth information and allow the isolation of all the vascular layers of the retina and the selected choroidal layers.

Additionally, the development of newer OCT devices- such as spectral-domain OCT, tens of thousands of A-scans can be acquired each second, which enables true 3-D imaging a routine practice. Consequently, 3-D OCT is now in wide clinical use and has become the standard of care. Therefore, the constant technological advancements coupled with added advantages of the OCT imaging equipment among other product types is expected to boost the growth of the ophthalmic imaging equipment market.

Ophthalmic Imaging Equipment Market Scope

Study Period: 2018-2026

Key Companies: ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V., Optovue, Incorporated, Heidelberg Engineering Inc, NIDEK CO., LTD, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Sonomed Escalon, Keeler, Konan Medical USA, Inc., TOMEY CORPORATION, Rexxam Co. Ltd., HAAG-STREIT GROUP, Essilor Instruments USA Ltd, Ziemer Ophthalmic Systems, Costruzione Strumenti Oftalmici, Topcon Corporation, HAI Laboratories, Inc., Centervue SpA and others.

Segmentation: By Product Type, By Application, By End User and By Geography

Geography Covered: North America, Europe, Asia- Pacific, Rest of the World (Middle East, Africa, and South America)

Know more about which MedTech player is set to emerge as the trendsetter @ Key Ophthalmic Imaging Equipment Companies

Table of Contents

Ophthalmic Imaging Equipment Market Report Introduction
Ophthalmic Imaging Equipment Market Executive Summary
Regulatory and Patent Analysis
Ophthalmic Imaging Equipment Market Key Factors Analysis
Ophthalmic Imaging Equipment Market Porter’s Five Forces Analysis

6.COVID-19 Impact Analysis on Ophthalmic Imaging Equipment Market

Ophthalmic Imaging Equipment Market Layout
Ophthalmic Imaging Equipment Market Global Company Share Analysis – Key 3-5 Companies
Ophthalmic Imaging Equipment Market Company and Product Profiles
Project Approach
KOL Views
DelveInsight Capabilities
Disclaimer
About DelveInsight

Learn more about the Pre filled Syringes @ Ophthalmic Imaging Equipment Regulatory And Patent Analysis

Other Reports:

Related Blogs:

About Delveinsight:

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Ankit Nigam

Email: info@delveinsight.com

Phone: +19193216187

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com/

Connect With Us at:

LinkedIn | Facebook | Twitter

March 19, 2022

Market Research Report, Medical Device

Ophthalmic Imaging Equipment, Ophthalmic Imaging Equipment Market

Menorrhalgia Market Research Report 2030

(Albany, US) DelveInsight has launched a new report on “Menorrhalgia Market Insights, Epidemiology, and Market Forecast-2030“

DelveInsight’s “Menorrhalgia Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Menorrhalgia, historical and forecasted epidemiology as well as the Menorrhalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the facts:

Menorrhagia is a common problem in women of reproductive age group and 5% of women between 30 and 49 years of age group consult their general practitioner for this problem.
In the UK, 20% of all women, and 30% in the USA, have a hysterectomy before the age of 60; menorrhagia is the main presenting problem in at least 50-70%.
Around 16% to 37% of women with heavy menstrual bleeding are diagnosed with Von Willebrand disease (VWD) in US.

Request for Free Sample Report: https://www.delveinsight.com/sample-request/menorrhalgia-market

Scope of the Report

The Menorrhalgia report covers the descriptive overview of Menorrhalgia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Menorrhalgia epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Menorrhalgia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Menorrhalgia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Menorrhalgia market

Request for Free Sample Report: https://www.delveinsight.com/sample-request/menorrhalgia-market

Menorrhagiais the medical term for menstrual periods with abnormally heavy or prolonged bleeding. Although heavy menstrual bleeding is a common concern, most women don’t experience blood loss severe enough to be defined as menorrhagia.

With menorrhagia, you can’t maintain your usual activities when you have your period because you have so much blood loss and cramping. If you dread your period because you have such heavy menstrual bleeding, talk with your doctor. There are many effective treatments for menorrhagia.

Menorrhagia in adolescent girls is typically due to anovulation. Adolescent girls are especially prone to anovulatory cycles in the first year after their first menstrual period (menarche).

Menorrhagia in older reproductive-age women is typically due to uterine pathology, including fibroids, polyps and adenomyosis. However, other problems, such as uterine cancer, bleeding disorders, medication side effects and liver or kidney disease could be contributing factors.

Some of the Menorrhalgia Companies:

Torrent Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd
Beximco pharmaceuticals Ltd.
Zydus Cadila
Novartis AG
Apricus biosciences Inc.
Mayne Pharma Group Limited
Cipla Inc.
Pfizer Inc.
Bayer AG
Novo Nordisk A/S
And Many others.

Request for Free Sample Report: https://www.delveinsight.com/sample-request/menorrhalgia-market

Table of Contents:

1. Key Insights

2. Executive Summary of Menorrhalgia

3. Competitive Intelligence Analysis for Menorrhalgia

4. Menorrhalgia: Market Overview at a Glance

4.1. Menorrhalgia Total Market Share (%) Distribution in 2017

4.2. Menorrhalgia Total Market Share (%) Distribution in 2030

5. Menorrhalgia: Disease Background and Overview

7. Menorrhalgia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Menorrhalgia Treatment and Management

8.2. Menorrhalgia Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Menorrhalgia Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Menorrhalgia: Seven Major Market Analysis

13.1. Key Findings

13.2. Menorrhalgia Market Size in 7MM

13.3. Menorrhalgia Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Menorrhalgia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

Others Reports:

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/